Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.
The diagnosis, treatment, and monitoring of the primary systemic vasculitides associated with circulating antineutrophil cytoplasm autoantibodies (ANCA) have formed the focus of a multicenter collaborative study. Consensus has been reached on criteria for classification, clinical subgroupings by ext...
المؤلفون الرئيسيون: | Jayne, DR, Rasmussen, N |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
1997
|
مواد مشابهة
-
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
حسب: Mukhtyar, C, وآخرون
منشور في: (2006) -
Comments on: Antineutrophil cytoplasmic autoantibody associated vasculitis-Clinical profile and outcomes
حسب: Rohini Handa
منشور في: (2018-01-01) -
Ischaemic stroke as the first presentation of antineutrophilic cytoplasmic autoantibody‐associated vasculitis
حسب: John Chuan Nguyen Tran, وآخرون
منشور في: (2022-12-01) -
Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
حسب: Flossmann, O, وآخرون
منشور في: (2006) -
Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis with Kidney Involvement in a Patient with AL Amyloidosis
حسب: Brendan L. Thoms, وآخرون
منشور في: (2021-07-01)